Titlebook: Nuclear Medicine Therapy; Principles and Clini Cumali Aktolun,Stanley J. Goldsmith Book 2013 Springer Science+Business Media New York 2013

melancholy

書目名稱Nuclear Medicine Therapy影響因子(影響力)




書目名稱Nuclear Medicine Therapy影響因子(影響力)學科排名




書目名稱Nuclear Medicine Therapy網絡公開度




書目名稱Nuclear Medicine Therapy網絡公開度學科排名




書目名稱Nuclear Medicine Therapy被引頻次




書目名稱Nuclear Medicine Therapy被引頻次學科排名




書目名稱Nuclear Medicine Therapy年度引用




書目名稱Nuclear Medicine Therapy年度引用學科排名




書目名稱Nuclear Medicine Therapy讀者反饋




書目名稱Nuclear Medicine Therapy讀者反饋學科排名

Cacophonous

Radioimmunotherapy of Renal Cell Carcinoma The median tumor size is approximately 4 cm, well within safe limits for partial nephrectomy when technically feasible. Recent data demonstrate that 50–70% represent the more aggressive conventional clear cell carcinoma [4].

咽下

Radioiodine Therapy of Benign Thyroid Diseases: Graves’ Disease, Plummer’s Disease, Non-toxic Goiter, disadvantages, and limitations. This chapter focuses on the role of radioiodine therapy of benign thyroid diseases. Pertinent information is also provided on the basics of thyroid diseases, thyroid medication, and surgery.

maverick

lear Medicine Therapy .presents the state of the art in targeted radionuclide therapy, both in clinical practice and contemporary clinical investigation and trials. With contributions from an internationally-distinguished group of physicians and scientists, the book is devoted entirely to the use of

lipids

diathermy

Radiophosphorus Treatment of Myeloproliferative Neoplasmserative neoplasia. This chapter will review the history of radiophosphorus in medicine, the dosimetry of .P-phosphate, and important clinical applications of the radiopharmaceutical, as well as the controversy which arose around its potential for leukemogenesis and the current clinical role for sodium .P-phosphate.

惹人反感

滑動

Radiomicrosphere Therapy of Liver Tumors0 and clinical applications of Y-90 microspheres are steadily expanding. The growing experience brings more responsibility onto the nuclear medicine community, as some of the most critical questions and controversies in the practical daily clinical use of RMT are related to nuclear medicine techniques.

平項山

Radionuclide Therapy of Leukemias1,780 individuals would die from the disease (12,740 men and 9,040 women). In children younger than 14 years old, nearly one-third of the cancers diagnosed are leukemias (particularly acute lymphoblastic leukemia (ALL)) (Table 2.2).

vascular

Radionuclide Therapy of Neuroendocrine Tumors of axons and synapses, the production of cell type-specific hormonal products and the demonstration of particular histopathological staining [1]. The variation in biological characteristics of these tumors poses considerable problems when deciding the optimal treatment strategies.